Posted on 10/8/19
Cresco Labs Announces Closing of Acquisition in New York State
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multi state cannabis operators in the United States
Posted on 10/8/19
Goldman Exits Marathon Health
WINOOSKI, Vt. & NEW YORK--(BUSINESS WIRE)--Marathon Health, a leading provider of employer health centers, and General Atlantic, a leading global growth equity firm, today announced a . . .
Posted on 10/8/19
Here's Why PTC Therapeutics Fell 24.1% in September
What happenedShares of PTC Therapeutics (NASDAQ:PTCT) dropped more than 24% last month, according to data provided by S&P Global Market Intelligence. The biopharmaceutical company tumbled after . . .
Posted on 10/8/19
PTC Therapeutics Establishes Strategic Collaboration with Aldevron
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a collaboration with Aldevron, LLC to secure GMP manufacturing capacity for PTC's gene therapy portfolio, including the Friedreich ataxia . . .
Posted on 10/7/19
Nevakar Enters Into $17.5M Product Financing Agreement with H.I.G. Capital Partners
Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas
Posted on 10/7/19
Westmed Medical Group Generates $15.3 Million in Savings for Centers for Medicare & Medicaid (CMS) in 2018 Performance Year
Westmed Medical Group, an award-winning multispecialty medical practice based in Purchase, NY, announced today that it has saved the Centers for Medicare and Medicaid Services (CMS) . . .
Posted on 10/7/19
Better Buy: Procter & Gamble vs. Kimberly-Clark
Consumers probably couldn't go through a whole day without using at least one or more products from Kimberly-Clark (NYSE:KMB) and Procter & Gamble (NYSE:PG).The two consumer . . .
Posted on 10/4/19
Bristol-Myers Squibb On Roll With Opdivo Results
Summary Opdivo had positive trial results for esophageal cancer, melanoma, and non-small cell lung cancer. This should reassure investors that sales will continue to rise. Celgene . . .
Posted on 10/3/19
OncLive Reveals the 2019 Innovative Technology in Cancer Care Challenge Finalists
CRANBURY, N.J.--(BUSINESS WIRE)--OncLive, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best . . .
Posted on 10/3/19
MedicaSafe Announces Partnership with Amneal Pharmaceuticals
NEW YORK--(BUSINESS WIRE)--MedicaSafe, Inc. today announced a partnership with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) to provide Amneal’s generic version of Suboxone® (buprenorphine and naloxone) as part . . .
Posted on 10/3/19
GRYT Health Acquires Vivibot Chatbot
GRYT Health, an award-winning digital health company, today announced it has enhanced its platform with the availability of a desktop version of its GRYT digital app, and . . .
Posted on 10/3/19
3 Risks Teladoc Investors Should Consider
Teladoc Health (NYSE:TDOC) connects doctors with patients over video chats and phone calls -- so-called virtual visits. In this fast-growing market, the company is the largest . . .
Posted on 10/2/19
Biofourmis Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
CB Insights announced today at its Future of Health conference that Biofourmis, a Boston-based fast-growing global leader in digital therapeutics, has been named to the organization's . . .
Posted on 10/2/19
Lark Health Named to the 2019 CB Insights Digital Health 150
Lark Health, a chronic disease prevention and management platform, today announced it was named to CB Insight's inaugural Digital Health 150 ranking, which showcases the 150 . . .
Posted on 10/2/19
The Medicines Company Is Up 161% Year to Date, but Here's a Better Way to Play the Drugmaker's Success
The Medicines Company (NASDAQ:MDCO) is up 161% this year, thanks in large part to the success of its cholesterol-lowering drug inclisiran.In August, the company announced that . . .
Posted on 10/1/19
White Oak Healthcare Finance Provides $241 Million Financing for a 19 Facility Skilled Nursing Portfolio
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC today announced it acted as administrative agent and lead lender on the funding of a $241 million senior credit . . .
Posted on 10/1/19
2 Reasons I Remain Very Bullish On Merck
SummaryMerck's second quarter produced very good top and bottom line results.Keytruda has a long runway for growth and is under patent protection for quite some time.The . . .
Posted on 10/1/19
Immunomedics Provides Corporate Update
MORRIS PLAINS, N.J., Sept. 28, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today presented . . .
Posted on 9/30/19
WebMD to Acquire Aptus Health
WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals
Posted on 9/30/19
Is GlaxoSmithKline a Buy?
Over the past several years, British pharmaceutical giant GlaxoSmithKline (NYSE:GSK) has been struggling to compete against some of its peers in the big pharma space. Despite . . .
Posted on 9/30/19
Where Will Pfizer Be in 5 Years?
Pfizer (NYSE:PFE) is America's largest pharmaceutical company, but it's about to become a lot smaller. A narrow focus could lead to explosive growth, but it won't . . .
Posted on 9/30/19
Better Buy: Gilead Sciences vs. Pfizer
If you're looking for solid dividend stocks, big drugmakers are a good place to start. And among the big drug stocks, few offer dividends as attractive . . .
Posted on 9/29/19
Healthfirst Expands Presence In Chinatown
Healthfirst, New York's largest not-for-profit health insurance company (with nearly 1.4 million members), proudly announces the opening of its new storefront community office location at 28 . . .
Posted on 9/29/19
Relmada Therapeutics Announces Reverse Stock Split
Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that its Board of . . .
Posted on 9/29/19
Citius Closes $7.0M Underwritten Offering Priced At-the-Market
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously . . .

